The Boston Scientific ENOVUS Trial

NCT00246038 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-08-31

No results posted yet for this study

Summary

A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when used in the treatment of patients with AAA (Treatment Group) as compared to patients treated with conventional open surgery (Control Group).

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

Boston Scientific ENOVUS AAA Endograft

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Rodney A. White, MD; Chief, Vascular Surgery · University of California, Los Angeles

  • W. Anthony Lee, MD; Assistant Professor of Surgery · University of Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00246038 on ClinicalTrials.gov